Skip to main content
Sparge Chem Logo
Sparge Chem
"Passion For Innovation"
* Research Use Only

Documents

COA
SDS / Safety Data

[(2R,3R,4R,5S)-3-benzoyloxy-5-bromo-4-fluoro-4-methyloxolan-2-yl]methyl benzoate

CAS No.:
Cat. No.: SC21159
Available on Request

Price on Request

Contact us for pricing, MOQ, and lead time

Bulk Inquiry
Product Name :[(2R,3R,4R,5S)-3-benzoyloxy-5-bromo-4-fluoro-4-methyloxolan-2-yl]methyl benzoate
Cat. No.: :SC21159
Purity / Specification :—
CAS No. :1233335-84-6
MDL No. :—
Molecular Formula :C20H18BrFO5
LogP :4.60
Molecular Weight :437.26
TPSA :61.8
Category :Building Blocks
HSN Code :—
SMILES Code :C[C@]1(F)[C@H](Br)O[C@H](COC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1
Melting Point :—
InChI Key : :BXKUNDXPWMNAMP-XNFNUYLZSA-N
Boiling Point :No data available

Application Note

AI Generated

Generated by AI. Verify before use in regulatory documents.

Lipinski & ADMET Properties

Computational estimate

Lipinski Rule of 5

i
✓ PASS
MW ≤ 500 Da✓ 437.3 Da
LogP ≤ 5✓ 4.60
HBD ≤ 5✓ 0
HBA ≤ 10✓ 6

Max 1 violation allowed for oral bioavailability.

Drug-likeness Score

i
68/100

Moderate — typical building block

Predicted LogP

i
4.60log units

Lipophilic

CNS Permeability

i

Clark model · J Pharm Sci, 1999

CNS± borderline

TPSA 61.8Ų · Threshold: <60 CNS+ · 60–90 CNS± · >90 CNS−

Requires experimental confirmation.

⚠ These are computational estimates based on Lipinski & Veber physicochemical rules. They are not validated ADMET predictions and must not be used for clinical, regulatory, or safety decisions. For research use only.